MTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells

Photochemistry and Photobiology

Volumn 88, Issue 3, 2012, Pages 721-727

  Reidy, Kerstin ^a   Campanile, Carmen ^a   Muff, Roman ^a   Born, Walter ^a   Fuchs, Bruno ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESOPORPHYRIN; PHOTOSENSITIZING AGENT; TEMOPORFIN;

APOPTOSIS; ARTICLE; BONE TUMOR; HUMAN; METASTASIS; OSTEOSARCOMA; PATHOLOGY; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; HUMANS; MESOPORPHYRINS; NEOPLASM METASTASIS; OSTEOSARCOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

ANIMALIA; MUS;

EID: 84860666118     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2012.01096.x     Document Type: Article

References (30)

1. Longhi, A., C. Errani, M. De Paolis, M. Mercuri, and, G. Bacci, (2006) Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat. Rev. 32, 423-436.
2. Friedman, M. A., and, S. K. Carter, (1972) The therapy of osteogenic sarcoma: current status and thoughts for the future. J. Surg. Oncol. 4, 482-510.
3. Weinfeld, M. S., and, H. R. Dudley Jr,. (1962) Osteogenic sarcoma. A follow-up study of the ninety-four cases observed at the Massachusetts General Hospital from 1920 to 1960. J. Bone Joint Surg. Am. 44-A, 269-276.
4. Bielack, S. S., B. Kempf-Bielack, G. Delling, G. U. Exner, S. Flege, K. Helmke, R. Kotz, M. Salzer-Kuntschik, M. Werner, W. Winkelmann, A. Zoubek, H. Jurgens, and, K. Winkler, (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 20, 776-790.
5. Bielack, S. S., J. N. Machatschek, S. Flege, and, H. Jurgens, (2004) Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin. Pharmacother. 5, 1243-1256.
6. Kager, L., A. Zoubek, U. Potschger, U. Kastner, S. Flege, B. Kempf-Bielack, D. Branscheid, R. Kotz, M. Salzer-Kuntschik, W. Winkelmann, G. Jundt, H. Kabisch, P. Reichardt, H. Jurgens, H. Gadner, and, S. S. Bielack, (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J. Clin. Oncol. 21, 2011-2018.
7. Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson, and, J. Golab, (2011) Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61, 250-281.
8. Juarranz, A., P. Jaen, F. Sanz-Rodriguez, J. Cuevas, and, S. Gonzalez, (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncol. 10, 148-154.
9. Dolmans, D. E., D. Fukumura, and, R. K. Jain, (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387.
10. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and, Q. Peng, (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889-905.
11. Fingar, V. H., T. J. Wieman, S. A. Wiehle, and, P. B. Cerrito, (1992) The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52, 4914-4921.
12. Gomer, C. J., A. Ferrario, M. Luna, N. Rucker, and, S. Wong, (2006) Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg. Med. 38, 516-521.
13. Korbelik, M., (1996) Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg. 14, 329-334.
14. Chang, A. E., and, V. K. Sondak, (1995) Clinical evaluation and treatment of soft tissue tumors. In Soft Tissue Tumors (Edited by, F. M. Enzinger, and, S. W. Weiss,), pp. 17-38. C.V. Mosby, St. Louis.
15. Dorfman, H. D., and, B. Czerniak, (1988) General considerations. In Bone Tumors (Edited by, H. D. Dorfman, and, B. Czerniak,), pp. 1-33. C.V. Mosby, St. Louis.
16. Burch, S., C. London, B. Seguin, C. Rodriguez, B. C. Wilson, and, S. K. Bisland, (2009) Treatment of canine osseous tumors with photodynamic therapy: a pilot study. Clin. Orthop. Relat. Res. 467, 1028-1034.
17. Coutier, S., L. N. Bezdetnaya, T. H. Foster, R. M. Parache, and, F. Guillemin, (2002) Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat. Res. 158, 339-345.
18. Coutier, S., S. Mitra, L. N. Bezdetnaya, R. M. Parache, I. Georgakoudi, T. H. Foster, and, F. Guillemin, (2001) Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids. Photochem. Photobiol. 73, 297-303.
19. Ma, L., J. Moan, and, K. Berg, (1994) Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int. J. Cancer 57, 883-888.
20. Mitra, S., and, T. H. Foster, (2005) Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin. Photochem. Photobiol. 81, 849-859.
21. Arlt, M. J., I. J. Banke, D. K. Walters, G. J. Puskas, P. Steinmann, R. Muff, W. Born, and, B. Fuchs, (2011) LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. J. Orthop. Res. 29, 938-946.
22. Marina, N., M. Gebhardt, L. Teot, and, R. Gorlick, (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9, 422-441.
23. Lassalle, H. P., M. Wagner, L. Bezdetnaya, F. Guillemin, and, H. Schneckenburger, (2008) Fluorescence imaging of Foscan and Foslip in the plasma membrane and in whole cells. J. Photochem. Photobiol. B 92, 47-53.
24. Teiten, M. H., L. Bezdetnaya, P. Morliere, R. Santus, and, F. Guillemin, (2003) Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br. J. Cancer 88, 146-152.
25. Kessel, D., (1999) Transport and localisation of m-THPC in vitro. Int. J. Clin. Pract. 53, 263-267.
26. Yow, C. M., J. Y. Chen, N. K. Mak, N. H. Cheung, and, A. W. Leung, (2000) Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative. Cancer Lett. 157, 123-131.
27. Leung, W. N., X. Sun, N. K. Mak, and, C. M. Yow, (2002) Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis. Photochem. Photobiol. 75, 406-411.
28. Kiesslich, T., J. Berlanda, K. Plaetzer, B. Krammer, and, F. Berr, (2007) Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Photochem. Photobiol. Sci. 6, 619-627.
29. Oleinick, N. L., R. L. Morris, and, I. Belichenko, (2002) The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 1, 1-21.
30. Dahle, J., H. B. Steen, and, J. Moan, (1999) The mode of cell death induced by photodynamic treatment depends on cell density. Photochem. Photobiol. Sci. 70, 363-367.